Serratia Myositis in an Intravenous Drug User
DOI:
https://doi.org/10.2015/hc.v9i3.571Keywords:
Serratia, fever, myositis, pyomyositis, intravenous drug userAbstract
Serratia marcescens is a well-known causative agent of hospital-acquired infections, especially in the intensive care unit (ICU), but can also cause community-acquired infections. Infectious myositis due to Serratia is an extremely rare infection. We present a rare case of myositis due to Serratia marcescens in an intravenous drug user. To the best of our knowledge this is the first case of Serratia marcescens infectious myositis in an intravenous drug user. Our report not only reminds us that Serratia marcescens could be a pathogen in the community, but also highlights the fact that drug users are a special population with rare and unusual infections and as a result the clinician must have a high clinical suspicion and vigilance in order to diagnose and treat them.Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
